BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10975803)

  • 1. Amelioration of experimental autoimmune uveoretinitis by pretreatment with a pathogenic peptide in liposome and anti-CD40 ligand monoclonal antibody.
    Namba K; Ogasawara K; Kitaichi N; Morohashi T; Sasamoto Y; Kotake S; Matsuda H; Iwabuchi K; Iwabuchi C; Ohno S; Onoé K
    J Immunol; 2000 Sep; 165(6):2962-9. PubMed ID: 10975803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a peptide inducing experimental autoimmune uveoretinitis (EAU) in H-2Ak-carrying mice.
    Namba K; Ogasawara K; Kitaichi N; Matsuki N; Takahashi A; Sasamoto Y; Kotake S; Matsuda H; Iwabuchi K; Ohno S; Onoé K
    Clin Exp Immunol; 1998 Feb; 111(2):442-9. PubMed ID: 9486417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
    Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance.
    Bagenstose LM; Agarwal RK; Silver PB; Harlan DM; Hoffmann SC; Kampen RL; Chan CC; Caspi RR
    J Immunol; 2005 Jul; 175(1):124-30. PubMed ID: 15972638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of spontaneous uveoretinitis development by non-immunopathogenic peptide immunization.
    Takeuchi M; Kezuka T; Inoue H; Sakai J; Usui M; Takahashi T; Taguchi O
    Eur J Immunol; 1998 May; 28(5):1578-86. PubMed ID: 9603463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping immune responses to mRBP-3 1-16 peptide with altered peptide ligands.
    Guyver CJ; Copland DA; Calder CJ; Sette A; Sidney J; Dick AD; Nicholson LB
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2027-35. PubMed ID: 16639012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance.
    Silver PB; Hathcock KS; Chan CC; Wiggert B; Caspi RR
    J Immunol; 2000 Nov; 165(9):5041-7. PubMed ID: 11046033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor.
    Zhang L; Ma J; Takeuchi M; Usui Y; Hattori T; Okunuki Y; Yamakawa N; Kezuka T; Kuroda M; Goto H
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2109-17. PubMed ID: 20007828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of monoclonal antibodies directed at cell surface molecules on murine experimental autoimmune uveoretinitis.
    Ando K; Fujino Y; Mochizuki M
    Graefes Arch Clin Exp Ophthalmol; 1999 Oct; 237(10):848-54. PubMed ID: 10502060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.
    Yokoi H; Kato K; Kezuka T; Sakai J; Usui M; Yagita H; Okumura K
    Eur J Immunol; 1997 Mar; 27(3):641-6. PubMed ID: 9079803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
    Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
    Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells.
    Jiang HR; Muckersie E; Robertson M; Forrester JV
    Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1598-607. PubMed ID: 12657598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-mediated suppression of experimental autoimmune uveoretinitis in mice: development of a peptide vaccine.
    Kezuka T; Sakai J; Yokoi H; Takeuchi M; Okada A; Taguchi O; Usui M; Mizuguchi J
    Int Immunol; 1996 Aug; 8(8):1229-35. PubMed ID: 8918692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
    Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of experimental autoimmune uveoretinitis by regulatory dendritic cells in mice.
    Usui Y; Takeuchi M; Hattori T; Okunuki Y; Nagasawa K; Kezuka T; Okumura K; Yagita H; Akiba H; Goto H
    Arch Ophthalmol; 2009 Apr; 127(4):514-9. PubMed ID: 19365033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mimicry epitope from Ehrlichia canis for interphotoreceptor retinoid-binding protein 201-216 prevents autoimmune uveoretinitis by acting as altered peptide ligand.
    Gangaplara A; Massilamany C; Steffen D; Reddy J
    J Neuroimmunol; 2013 Oct; 263(1-2):98-107. PubMed ID: 24029580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies.
    Kitaichi N; Matsuda A; Kotake S; Namba K; Tagawa Y; Sasamoto Y; Ogasawara K; Iwabuchi K; Onoé K; Matsuda H; Nishihira J
    Curr Eye Res; 2000 Feb; 20(2):109-14. PubMed ID: 10617911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.